Skip to main content

Nexagen, LLC Recall: Product contains insufficient Higenamine and the label incorrectly declares Cayenne Pepper (CapsiMax) and Choline Bitartrate.

United States

OngoingClass II

Company
Nexagen, LLC
Product
ACID RAIN ASS KICKING FAT DESTROYER APOCALYPSE LABZ; 45 CAPS…
Recall date
May 28, 2019
Source
FDA

Reason for recall

Product contains insufficient Higenamine and the label incorrectly declares Cayenne Pepper (CapsiMax) and Choline Bitartrate.

  1. - Recall initiated
  2. - Reported by source
Recalled products
Product description UPC Quantity Lot / code information
ACID RAIN ASS KICKING FAT DESTROYER APOCALYPSE LABZ; 45 CAPSULES; 1 DIETARY SUPPLEMENT; UPC 6 11138 28792 0 Not published in this source record 157 bottles/45 capsules Lot #9005860 EXP: 1282020

Distribution

  • Product was distributed to the following states: AL
  • FL
  • GA
  • NM
  • TN & TX.

Official source record

Agency
FDA
Dataset
FDA Food Enforcement (Recalls)
Recall number
F-1942-2019
Event ID
82853
Status
Ongoing
Classification
Class II
Company
Nexagen, LLC
Product description
ACID RAIN ASS KICKING FAT DESTROYER APOCALYPSE LABZ; 45 CAPSULES; 1 DIETARY SUPPLEMENT; UPC 6 11138 28792 0
Quantity
157 bottles/45 capsules
Reason
Product contains insufficient Higenamine and the label incorrectly declares Cayenne Pepper (CapsiMax) and Choline Bitartrate.
Recall initiation date
May 28, 2019
Report date
July 31, 2019
Classification date
Not published in this source record
Termination date
Not terminated as of this source record
Distribution pattern
Product was distributed to the following states: AL, FL, GA, NM, TN & TX.
UPC, lot, and code information
Lot #9005860 EXP: 1282020
Voluntary or mandated
Voluntary: Firm initiated
Initial notification method
Letter
Source last updated
Not tracked separately from the Public Health Trace retrieval date below
Public Health Trace retrieval date

Responsible company: Nexagen, LLC

Distribution map

A map highlighting the states named in the source's distribution description.

Shading reflects state-level totals only, as published by the source. It does not imply county-level or point-level precision.

Distribution map
State Distributed
Alabama 1
Florida 1
Georgia 1
New Mexico 1
Tennessee 1
Texas 1

States shown are extracted from the source's free-text distribution description above; a narrative description (e.g. "distributed nationwide") may not list individual states to extract.

Where this information comes from

View FDA enforcement record -- the specific openFDA record this summary was built from.

No separate FDA public notice was found for this enforcement record. The information below comes from FDA's Recall Enterprise System through openFDA.

FDA Enforcement Reports -- FDA's general, official recall and enforcement information.

Technical source data

View raw source data -- the machine-readable record this page's information was built from.

Retrieved by Public Health Trace:

Frequently asked questions

What does a Class II mean?

A situation in which use of or exposure to a product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote.

Is this recall still active?

According to FDA, this recall's status is "Ongoing." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.

What should I do if I have this product?

Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.

Where can I find more official information?

The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.

This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.